This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Cancer Research Technology Limited, Redx Pharma Limited, The Institute of Cancer Research. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 268 
1 out of 27 
1 out of 24 
Years Active: 2024-2026
Title: Ana Varela Rodriguez: Innovator in Cancer Research
Introduction
Ana Varela Rodriguez is a prominent inventor based in London, GB. She has made significant contributions to the field of cancer research, particularly through her innovative work on inhibitors of BCL6 activity. Her research focuses on developing compounds that can potentially treat proliferative disorders, including various forms of cancer.
Latest Patents
Ana holds a patent for "Benzimidazolone derived inhibitors of BCL6." This invention relates to compounds of Formula I that function as inhibitors of BCL6 (B-cell lymphoma 6) activity. The patent outlines processes for the preparation of these compounds, pharmaceutical compositions that include them, and their applications in treating diseases where BCL6 activity is implicated.
Career Highlights
Throughout her career, Ana has worked with notable organizations such as Cancer Research Technology Limited and the Institute of Cancer Research. Her work has been instrumental in advancing the understanding and treatment of cancer through innovative therapeutic approaches.
Collaborations
Ana has collaborated with esteemed colleagues, including Benjamin Richard Bellenie and Michael K Carter. These partnerships have further enriched her research and contributed to the development of effective cancer treatments.
Conclusion
Ana Varela Rodriguez is a dedicated inventor whose work in cancer research has the potential to make a significant impact on the treatment of proliferative disorders. Her innovative approach and collaboration with leading experts in the field highlight her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile